Eaton Vance Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.54M | Sell |
410,828
-258
| -0.1% | -$2.22K | 0.01% | 874 |
|
|
2022
Q2 | $3.35M | Sell |
411,086
-26,056
| -6% | -$212K | ﹤0.01% | 921 |
|
|
2022
Q1 | $5.31M | Buy |
437,142
+24,182
| +6% | +$294K | 0.01% | 870 |
|
|
2021
Q4 | $14.1M | Sell |
412,960
-613
| -0.1% | -$20.9K | 0.02% | 548 |
|
|
2021
Q3 | $19.8M | Buy |
413,573
+41,138
| +11% | +$1.97M | 0.03% | 429 |
|
|
2021
Q2 | $16.8M | Buy |
372,435
+118,688
| +47% | +$5.36M | 0.02% | 488 |
|
|
2021
Q1 | $12.2M | Buy |
253,747
+1,719
| +0.7% | +$82.9K | 0.02% | 528 |
|
|
2020
Q4 | $13.6M | Buy |
252,028
+38,327
| +18% | +$2.06M | 0.02% | 481 |
|
|
2020
Q3 | $7.88M | Buy |
213,701
+21
| +0% | +$775 | 0.01% | 533 |
|
|
2020
Q2 | $6.62M | Sell |
213,680
-8
| -0% | -$248 | 0.01% | 541 |
|
|
2020
Q1 | $5.9M | Buy |
+213,688
| New | +$5.9M | 0.01% | 508 |
|